Skip to main content
SpringerLink
Log in

Responses of Candida albicans to the human antimicrobial peptide LL-37

  • Published:
Journal of Microbiology Aims and scope Submit manuscript

Abstract

Candida albicans is amajor fungal pathogen in humans. Antimicrobial peptides (AMPs) are critical components of the innate immune response in vertebrates and represent the first line of defense against microbial infection. LL-37 is the only member of the human family of cathelicidin AMPs and is commonly expressed by various tissues and cells, including surfaces of epithelia. The candidacidal effects of LL-37 have been well documented, but the mechanisms by which LL-37 kills C. albicans are not completely understood. In this study, we examined the effects of LL-37 on cell wall and cellular responses in C. albicans. Using transmission electron microscopy, carbohydrate analyses, and staining for β-1,3-glucan, changing of C. albicans cell wall integrity was detected upon LL-37 treatment. In addition, LL-37 also affected cell wall architecture of the pathogen. Finally, DNA microarray analysis and quantitative PCR demonstrated that sub-lethal concentrations of LL-37 modulated the expression of genes with a variety of functions, including transporters, regulators for biological processes, response to stress or chemical stimulus, and pathogenesis. Together, LL-37 induces complex responses in C. albicans, making LL-37 a promising candidate for use as a therapeutic agent against fungal infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Refrerences

  • Adams, D.J. 2004. Fungal cell wall chitinases and glucanases. Microbiology 150, 2029–2035.

    Article  CAS  PubMed  Google Scholar 

  • Bergsson, G., Reeves, E.P., McNally, P., Chotirmall, S.H., Greene, C.M., Greally, P., Murphy, P., O’Neill, S.J., and McElvaney, N.G. 2009. LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J. Immunol. 183, 543–551.

    Article  CAS  PubMed  Google Scholar 

  • Bowdish, D.M., Davidson, D.J., Lau, Y.E., Lee, K., Scott, M.G., and Hancock, R.E. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77, 451–459.

    Article  CAS  PubMed  Google Scholar 

  • Boxx, G.M., Kozel, T.R., Nishiya, C.T., and Zhang, M.X. 2010. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans. Infect. Immun. 78, 1250–1259.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Braun, B.R., Kadosh, D., and Johnson, A.D. 2001. NRG1, a repressor of filamentous growth in C. albicans, is down-regulated during filament induction. Embo. J. 20, 4753–4761.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Brogden, K.A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238–250.

    CAS  Google Scholar 

  • Bulik, D.A., Olczak, M., Lucero, H.A., Osmond, B.C., Robbins, P.W., and Specht, C.A. 2003. Chitin synthesis in Saccharomyces cerevisiae in response to supplementation of growth medium with glucosamine and cell wall stress. Eukaryot. Cell 2, 886–900.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Burton, M.F. and Steel, P.G. 2009. The chemistry and biology of LL-37. Nat. Prod. Rep. 26, 1572–1584.

    Article  CAS  PubMed  Google Scholar 

  • Chang, H.T., Tsai, P.W., Huang, H.H., Liu, Y.S., Chien, T.S., and Lan, C.Y. 2012. LL37 and hBD-3 elevate the beta-1,3-exoglucanase activity of Candida albicans Xog1p, resulting in reduced fungal adhesion to plastic. Biochem. J. 441, 963–970.

    Article  CAS  PubMed  Google Scholar 

  • den Hertog, A.L., van Marle, J., van Veen, H.A., Van’t Hof, W., Bolscher, J.G., Veerman, E.C., and Nieuw Amerongen, A.V. 2005. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J. 388, 689–695.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • den Hertog, A.L., van Marle, J., Veerman, E.C.I., Valentijn-Benz, M., Nazmi, K., Kalay, H., Grun, C.H., van’t Hof, W., Bolscher, J.G.M., and Amerongen, A.V.N. 2006. The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol. Chem. 387, 1495–1502.

    Article  CAS  PubMed  Google Scholar 

  • Desai, J.V., Bruno, V.M., Ganguly, S., Stamper, R.J., Mitchell, K.F., Solis, N., Hill, E.M., Xu, W., Filler, S.G., Andes, D.R., and et al. 2013. Regulatory role of glycerol in Candida albicans biofilm formation. mBio 4, e00637-0062.

    Google Scholar 

  • Dorschner, R.A., Pestonjamasp, V.K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G.H., and Galloet, R.L. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117, 91–97.

    Article  CAS  PubMed  Google Scholar 

  • Dubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., and Smith, F. 1956. Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350–356.

    Article  CAS  Google Scholar 

  • Edmond, M.B., Wallace, S.E., McClish, D.K., Pfaller, M.A., Jones, R.N., and Wenzel, R.P. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29, 239–244.

    Article  CAS  PubMed  Google Scholar 

  • Eggimann, P., Garbino, J., and Pittet, D. 2003. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3, 685–702.

    Article  PubMed  Google Scholar 

  • Finkel, J.S., Xu, W., Huang, D., Hill, E.M., Desai, J.V., Woolford, C.A., Nett, J.E., Taff, H., Norice, C.T., Andes, D.R., and et al. 2012. Portrait of Candida albicans adherence regulators. PLoS Pathog. 8, e100225.

    Google Scholar 

  • Fonzi, W.A. 1999. PHR1 and PHR2 of Candida albicans encode putative glycosidases required for proper cross-linking of beta- 1,3- and beta-1,6-glucans. J. Bacteriol. 181, 7070–7079.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Francois, J.M. 2006. A simple method for quantitative determination of polysaccharides in fungal cell walls. Nat. Protoc. 1, 2995–3000.

    Article  CAS  PubMed  Google Scholar 

  • Galan-Diez, M., Arana, D.M., Serrano-Gomez, D., Kremer, L., Casasnovas, J.M., Ortega, M., Cuesta-Dominguez, A., Corbi, A.L., Pla, J., and Fernandez-Ruiz, E. 2010. Candida albicans betaglucan exposure is controlled by the fungal CEK1-mediated mitogen- activated protein kinase pathway that modulates immune responses triggered through dectin-1. Infect. Immun. 78, 1426–1416.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gonzalez, M.M., Diez-Orejas, R., Molero, G., Alvarez, A.M., Pla, J., Nombela, C., and Sanchez-Perez, M. 1997. Phenotypic characterization of a Candida albicans strain deficient in its major exoglucanase. Microbiology 143(Pt 9), 3023–3032.

    Article  PubMed  Google Scholar 

  • Henzler Wildman, K.A., Lee, D.K., and Ramamoorthy, A. 2003. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42, 6545–6558.

    Article  CAS  PubMed  Google Scholar 

  • Hsu, P.C., Chao, C.C., Yang, C.Y., Ye, Y.L., Liu, F.C., Chuang, Y.J., and Lan, C.Y. 2013. Diverse Hap43-independent functions of the Candida albicans CCAAT-binding complex. Eukaryot. Cell 12, 804–815.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hurtado-Guerrero, R., Schuttelkopf, A.W., Mouyna, I., Ibrahim, A.F., Shepherd, S., Fontaine, T., Latge, J.P., and van Aalten, D.M. 2009. Molecular mechanisms of yeast cell wall glucan remodeling. J. Biol. Chem. 284, 8461–8469.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jenssen, H., Hamill, P., and Hancock, R.E. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491–511.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Johansson, J., Gudmundsson, G.H., Rottenberg, M.E., Berndt, K.D., and Agerberth, B. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273, 3718–3724.

    Article  CAS  PubMed  Google Scholar 

  • Kai-Larsen, Y. and Agerberth, B. 2008. The role of the multifunctional peptide LL-37 in host defense. Front Biosci. 13, 3760–3767.

    Article  CAS  PubMed  Google Scholar 

  • Klis, F.M., de Groot, P., and Hellingwerf, K. 2001. Molecular organization of the cell wall of Candida albicans. Med. Mycol. 39 Suppl 1, 1–8.

    Article  Google Scholar 

  • Kollar, R., Reinhold, B.B., Petrakova, E., Yeh, H.J., Ashwell, G., Drgonova, J., Kapteyn, J.C., Klis, F.M., and Cabib, E. 1997. Architecture of the yeast cell wall. Beta(1→6)-glucan interconnects mannoprotein, beta(1→)3-glucan, and chitin. J. Biol. Chem. 272, 17762–17775.

    CAS  Google Scholar 

  • Kumar, R., Chadha, S., Saraswat, D., Bajwa, J.S., Li, R.A., Conti, H.R., and Edgerton, M. 2011. Histatin 5 uptake by Candida albicans utilizes polyamine transporters Dur3 and Dur31 proteins. J. Biol. Chem. 286, 43748–43758.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lesage, G. and Bussey, H. 2006. Cell wall assembly in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 70, 317–343.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Li, R., Kumar, R., Tati, S., Puri, S., and Edgerton, M. 2013. Candida albicans flu1-mediated efflux of salivary histatin 5 reduces its cytosolic concentration and fungicidal activity. Antimicrob. Agents Chemother. 57, 1832–1839.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lopez-Garcia, B., Lee, P.H.A., Yamasaki, K., and Gallo, R.L. 2005. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Invest. Dermatol. 125, 108–115.

    Article  CAS  PubMed  Google Scholar 

  • Luo, L., Tong, X., and Farley, P.C. 2007. The Candida albicans gene HGT12 (orf19.7094) encodes a hexose transporter. FEMS Immunol. Medical Microbiol. 51, 14–17.

    Article  CAS  Google Scholar 

  • Martinez-Esparza, M., Sarazin, A., Jouy, N., Poulain, D., and Jouault, T. 2006. Comparative analysis of cell wall surface glycan expression in Candida albicans and Saccharomyces cerevisiae yeasts by flow cytometry. J. Immunol. Methods 314, 90–102.

    Article  CAS  PubMed  Google Scholar 

  • Masuoka, J. 2004. Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges. Clin. Microbiol. Rev. 17, 281–310.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Mio, T., Yamada-Okabe, T., Yabe, T., Nakajima, T., Arisawa, M., and Yamada-Okabe, H. 1997. Isolation of the Candida albicans homologs of Saccharomyces cerevisiae KRE6 and SKN1: expression and physiological function. J. Bacteriol. 179, 2363–2372.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Murad, A.M., Leng, P., Straffon, M., Wishart, J., Macaskill, S., MacCallum, D., Schnell, N., Talibi, D., Marechal, D., Tekaia, F., and et al. 2001. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. Embo. J. 20, 4742–4752.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Nather, K. and Munro, C.A. 2008. Generating cell surface diversity in Candida albicans and other fungal pathogens. FEMS Microbiol. Lett. 285, 137–145.

    Article  CAS  PubMed  Google Scholar 

  • Nijnik, A. and Hancock, R.E. 2009. The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr. Opin. Hematol. 16, 41–47.

    Article  CAS  PubMed  Google Scholar 

  • Nobile, C.J., Fox, E.P., Nett, J.E., Sorrells, T.R., Mitrovich, Q.M., Hernday, A.D., Tuch, B.B., Andes, D.R., and Johnson, A.D. 2012. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell 148, 126–138.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Overhage, J., Campisano, A., Bains, M., Torfs, E.C., Rehm, B.H., and Hancock, R.E. 2008. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 76, 4176–4182.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pfaller, M.A. and Diekema, D.J. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133–163.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Pietiainen, M., Gardemeister, M., Mecklin, M., Leskela, S., Sarvas, M., and Kontinen, V.P. 2005. Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. Microbiology 151, 1577–1592.

    Article  PubMed  Google Scholar 

  • Reddy, K.V., Yedery, R.D., and Aranha, C. 2004. Antimicrobial peptides: premises and promises. Int. J. Antimicrob. Agents 24, 536–547.

    Article  CAS  PubMed  Google Scholar 

  • Ruiz-Herrera, J., Elorza, M.V., Valentin, E., and Sentandreu, R. 2006. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res. 6, 14–29.

    Article  CAS  PubMed  Google Scholar 

  • Scouten, W.H. 1984. Methods of enzymatic analysis, 3rd Edition, Vol. 1, Fundamentals-Bergmeyer, Hu. J. Am. Chem. Soc. 106, 1535–1535.

    Google Scholar 

  • Senyurek, I., Paulmann, M., Sinnberg, T., Kalbacher, H., Deeg, M., Gutsmann, T., Hermes, M., Kohler, T., Gotz, F., Wolz, C., and et al. 2009. Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus. Antimicrob. Agents Chemother. 53, 2499–2509.

    Article  PubMed Central  PubMed  Google Scholar 

  • Sorensen, O.E., Follin, P., Johnsen, A.H., Calafat, J., Tjabringa, G.S., Hiemstra, P.S., and Borregaard, N. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951–3959.

    Article  CAS  PubMed  Google Scholar 

  • Tsai, P.W., Yang, C.Y., Chang, H.T., and Lan, C.Y. 2011a. Characterizing the role of cell-wall beta-1,3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37. PLoS ONE 6, e21394.

    Google Scholar 

  • Tsai, P.W., Yang, C.Y., Chang, H.T., and Lan, C.Y. 2011b. Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE 6, e17755.

    Google Scholar 

  • Turner, J., Cho, Y., Dinh, N.N., Waring, A.J., and Lehrer, R.I. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206–2214.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Vyas, V.K., Berkey, C.D., Miyao, T., and Carlson, M. 2005. Repressors Nrg1 and Nrg2 regulate a set of stress-responsive genes in Saccharomyces cerevisiae. Eukaryot. Cell. 4, 1882–1891.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Vylkova, S., Jang, W.S., Li, W., Nayyar, N., and Edgerton, M. 2007. Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway. Eukaryot. Cell. 6, 1876–1888.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wheeler, R.T. and Fink, G.R. 2006. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog. 2, e35.

    Google Scholar 

  • Wisplinghoff, H., Bischoff, T., Tallent, S.M., Seifert, H., Wenzel, R.P., and Edmond, M.B. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309–317.

    Article  PubMed  Google Scholar 

  • Wunder, D., Dong, J., Baev, D., and Edgerton, M. 2004. Human salivary histatin 5 fungicidal action does not induce programmed cell death pathways in Candida albicans. Antimicrob. Agents Chemother. 48, 110–115.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Yeaman, M.R. and Yount, N.Y. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu, 30013, Taiwan

    Pei-Wen Tsai, Yin-Lien Cheng & Chung-Yu Lan

  2. Department of Life Science, National Tsing Hua University, Hsinchu, 30013, Taiwan

    Chung-Yu Lan

  3. Institute of Statistics, National Tsing Hua University, Hsinchu, 30013, Taiwan

    Wen-Ping Hsieh

Authors
  1. Pei-Wen Tsai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yin-Lien Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wen-Ping Hsieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chung-Yu Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chung-Yu Lan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsai, PW., Cheng, YL., Hsieh, WP. et al. Responses of Candida albicans to the human antimicrobial peptide LL-37. J Microbiol. 52, 581–589 (2014). https://doi.org/10.1007/s12275-014-3630-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12275-014-3630-2

Keywords

Search

Navigation